|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 642 | 96 | 15.0 | 353 | 55.0 | 144 | 22.4 | 38 | 5.9 | 11 | 1.7 |
| 2015-2019 | 633 | 97 | 15.3 | 338 | 53.4 | 140 | 22.1 | 42 | 6.6 | 16 | 2.5 |
| 2014-2018 | 641 | 111 | 17.3 | 323 | 50.4 | 147 | 22.9 | 39 | 6.1 | 21 | 3.3 |
| 2013-2017 | 633 | 121 | 19.1 | 316 | 49.9 | 138 | 21.8 | 35 | 5.5 | 23 | 3.6 |
| 2012-2016 | 626 | 113 | 18.1 | 317 | 50.6 | 142 | 22.7 | 31 | 5.0 | 23 | 3.7 |
| 2011-2015 | 595 | 114 | 19.2 | 291 | 48.9 | 135 | 22.7 | 31 | 5.2 | 24 | 4.0 |
| 2010-2014 | 595 | 119 | 20.0 | 292 | 49.1 | 133 | 22.4 | 29 | 4.9 | 22 | 3.7 |
| 2009-2013 | 591 | 114 | 19.3 | 303 | 51.3 | 124 | 21.0 | 31 | 5.2 | 19 | 3.2 |
| 2008-2012 | 600 | 106 | 17.7 | 318 | 53.0 | 127 | 21.2 | 32 | 5.3 | 17 | 2.8 |
| 2007-2011 | 618 | 118 | 19.1 | 318 | 51.5 | 128 | 20.7 | 36 | 5.8 | 18 | 2.9 |
| 2006-2010 | 611 | 107 | 17.5 | 324 | 53.0 | 131 | 21.4 | 29 | 4.7 | 20 | 3.3 |
| 2005-2009 | 591 | 100 | 16.9 | 314 | 53.1 | 130 | 22.0 | 25 | 4.2 | 22 | 3.7 |
| 2004-2008 | 567 | 87 | 15.3 | 296 | 52.2 | 135 | 23.8 | 24 | 4.2 | 25 | 4.4 |
| 2003-2007 | 570 | 88 | 15.4 | 293 | 51.4 | 136 | 23.9 | 21 | 3.7 | 32 | 5.6 |
| 2002-2006 | 578 | 84 | 14.5 | 298 | 51.6 | 145 | 25.1 | 18 | 3.1 | 33 | 5.7 |
| 2001-2005 | 586 | 83 | 14.2 | 311 | 53.1 | 142 | 24.2 | 19 | 3.2 | 31 | 5.3 |
| 2000-2004 | 613 | 89 | 14.5 | 318 | 51.9 | 153 | 25.0 | 23 | 3.8 | 30 | 4.9 |
| 1999-2003 | 629 | 93 | 14.8 | 334 | 53.1 | 152 | 24.2 | 25 | 4.0 | 25 | 4.0 |
| 1998-2002 | 604 | 90 | 14.9 | 314 | 52.0 | 150 | 24.8 | 25 | 4.1 | 25 | 4.1 |
| 1997-2001 | 577 | 85 | 14.7 | 298 | 51.6 | 137 | 23.7 | 25 | 4.3 | 32 | 5.5 |
| 1996-2000 | 563 | 85 | 15.1 | 290 | 51.5 | 130 | 23.1 | 22 | 3.9 | 36 | 6.4 |
| 1995-1999 | 514 | 73 | 14.2 | 267 | 51.9 | 113 | 22.0 | 21 | 4.1 | 40 | 7.8 |
| 1994-1998 | 503 | 66 | 13.1 | 249 | 49.5 | 118 | 23.5 | 21 | 4.2 | 49 | 9.7 |
| 1993-1997 | 503 | 68 | 13.5 | 257 | 51.1 | 112 | 22.3 | 19 | 3.8 | 47 | 9.3 |
| 1992-1996 | 519 | 66 | 12.7 | 269 | 51.8 | 120 | 23.1 | 16 | 3.1 | 48 | 9.2 |
| 1991-1995 | 510 | 62 | 12.2 | 247 | 48.4 | 129 | 25.3 | 22 | 4.3 | 50 | 9.8 |
| 1990-1994 | 568 | 65 | 11.4 | 251 | 44.2 | 155 | 27.3 | 28 | 4.9 | 69 | 12.1 |
| 1989-1993 | 571 | 69 | 12.1 | 242 | 42.4 | 145 | 25.4 | 29 | 5.1 | 86 | 15.1 |
| 1988-1992 | 574 | 61 | 10.6 | 227 | 39.5 | 140 | 24.4 | 33 | 5.7 | 113 | 19.7 |
| 1987-1991 | 549 | 53 | 9.7 | 205 | 37.3 | 131 | 23.9 | 35 | 6.4 | 125 | 22.8 |
| 1986-1990 | 533 | 49 | 9.2 | 195 | 36.6 | 129 | 24.2 | 35 | 6.6 | 125 | 23.5 |
| 1985-1989 | 478 | 38 | 7.9 | 194 | 40.6 | 105 | 22.0 | 34 | 7.1 | 107 | 22.4 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |